DIAMICRON

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Germany, Ecuador, Spain, France, Hong Kong, Ireland, Italy, Malta, Mexico, Nigeria, Netherlands, Poland, Singapore, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug DIAMICRON contains one active pharmaceutical ingredient (API):

1 Gliclazide UNII G4PX8C4HKV - GLICLAZIDE

Gliclazide is a hypoglycaemic sulfonylurea antidiabetic active substance. Gliclazide reduces blood glucose levels by stimulating insulin secretion from the β-cells of the islets of Langerhans. Read about Gliclazide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DIAMICRON MR Modified release tablet	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10BB09	Gliclazide	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BB Sulfonamides, urea derivatives
Discover more medicines within A10BB09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 9302N
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 531300504111317, 531300602113314, 531300603111315, 531300604116310, 531300605112319
Country: CA	Health Products and Food Branch	Identifier(s): 00765996, 02242987, 02356422
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 06488698, 06488706
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 29539-12-10, 29578-2-01-11
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 63644, 71738
Country: FR	Base de données publique des médicaments	Identifier(s): 60331738, 68419097, 68831670
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 138648, 143135, 14761, 161583, 36622, 36623
Country: HK	Department of Health Drug Office	Identifier(s): 46779, 60658
Country: IE	Health Products Regulatory Authority	Identifier(s): 46985, 69515, 69540
Country: IT	Agenzia del Farmaco	Identifier(s): 023404092, 023404231, 045454016, 045630011, 045637016, 045637028
Country: MT	Medicines Authority	Identifier(s): MA066/00601, MA066/00603, MA066/00604, PI1438/05001A, PI1438/05002A, PI521/07601A, PI770/10702A, PI770/10703A, PI908/00902A, PI908/00903A
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 022M2002
Country: NG	Registered Drug Product Database	Identifier(s): A4-7426, B4-9083
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 61530
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100135837
Country: SG	Health Sciences Authority	Identifier(s): 04316P, 11761P, 13868P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 6350013, 9163581, 9253881, 9253882
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699552030058, 8699552030065, 8699552030072, 8699552030089, 8699552030096
Country: ZA	Health Products Regulatory Authority	Identifier(s): 35/21.2/0178, 43/21.2/0957